CINECA IRIS Institutional Research Information System

Ferrero, Annamaria
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.024
EU - Europa 1.404
AS - Asia 703
SA - Sud America 47
OC - Oceania 27
AF - Africa 19
Totale 4.224
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.971
CN - Cina 440
IT - Italia 359
IE - Irlanda 207
FR - Francia 124
DE - Germania 98
FI - Finlandia 97
UA - Ucraina 92
GB - Regno Unito 77
SE - Svezia 74
KR - Corea 68
AT - Austria 63
PL - Polonia 56
VN - Vietnam 46
ES - Italia 39
JP - Giappone 39
BR - Brasile 29
IN - India 28
CA - Canada 26
MX - Messico 22
NL - Olanda 22
BE - Belgio 20
AU - Australia 19
TR - Turchia 17
TW - Taiwan 13
GR - Grecia 12
NO - Norvegia 12
HK - Hong Kong 11
ID - Indonesia 11
RO - Romania 11
SG - Singapore 11
NZ - Nuova Zelanda 8
DK - Danimarca 7
PH - Filippine 7
CL - Cile 6
LT - Lituania 6
NG - Nigeria 6
CO - Colombia 5
CZ - Repubblica Ceca 5
PT - Portogallo 5
RU - Federazione Russa 5
HR - Croazia 4
PE - Perù 4
AR - Argentina 3
BY - Bielorussia 3
TH - Thailandia 3
AE - Emirati Arabi Uniti 2
CH - Svizzera 2
CR - Costa Rica 2
DZ - Algeria 2
GH - Ghana 2
GT - Guatemala 2
HU - Ungheria 2
IR - Iran 2
MA - Marocco 2
MY - Malesia 2
SN - Senegal 2
ET - Etiopia 1
GE - Georgia 1
GN - Guinea 1
IL - Israele 1
KE - Kenya 1
MU - Mauritius 1
PA - Panama 1
PK - Pakistan 1
RS - Serbia 1
SI - Slovenia 1
ZA - Sudafrica 1
Totale 4.224
Salva come PNG Salva come JPEG
Città #
Beijing 275
Dublin 206
Chandler 201
Fairfield 126
Houston 98
Ashburn 83
Woodbridge 71
Villeurbanne 68
Torino 65
Jacksonville 61
Wilmington 61
Medford 58
Vienna 58
Princeton 56
Redwood City 53
Seattle 51
Ann Arbor 49
Pisa 47
Milan 42
Cambridge 39
Warsaw 38
Nyköping 32
Dearborn 30
Turin 28
Boston 26
Dong Ket 24
Verona 19
Fremont 18
Falls Church 15
Brussels 14
New York 14
Hefei 13
Nanjing 11
Norwalk 11
Rome 11
Shanghai 11
London 10
Rochester 10
San Diego 10
Zhengzhou 10
Jinan 9
Madrid 9
Berlin 8
Guangzhou 8
Hangzhou 8
Hebei 8
Oslo 8
Shenyang 8
Toronto 8
Athens 7
Boardman 7
Los Angeles 7
Swidnica 7
Taipei 7
Tokyo 7
Abuja 6
Assago 6
Changsha 6
Cleveland 6
Hong Kong 6
Jakarta 6
Lappeenranta 6
Munich 6
Nanchang 6
Naples 6
North Hollywood 6
Phoenix 6
Santiago 6
Helsinki 5
Hyderabad 5
Moscow 5
Mountain View 5
Paris 5
Piemonte 5
Recife 5
Bologna 4
Changchun 4
Chicago 4
Columbus 4
Durham 4
Faringdon 4
Istanbul 4
Kunming 4
Lachine 4
Lima 4
Mexico 4
Silver Spring 4
Singapore 4
Vilnius 4
Aberdeen 3
Albolote 3
Ankara 3
Apodaca 3
Baotou 3
Barceloneta 3
Brasov 3
Edmonton 3
Fuzhou 3
Indianapolis 3
Katowice 3
Totale 2.441
Salva come PNG Salva come JPEG
Nome #
Palliative care in patients with ovarian cancer and bowel obstruction 480
The Role of Surgery in Recurrent Endometrial Cancer 395
Endometriosis-associated Ovarian Cancer: A Distinct Clinical Entity? 220
Neoadjuvant platinum-based chemotherapy followed by radical hysterectomy for stage Ib2-IIb adenocarcinoma of the uterine cervix – An Italian multicenter retrospective study 151
Is carboplatin-paclitaxel combination the standard treatment of elderly ovarian cancer patients? 144
Is Ovarian Cancer Being Managed According to Clinical Guidelines? Evidence from a Population-Based Clinical Audit 121
The role of the French-Italian glossary of complications in the outcome evaluation of cervical cancer treatment: an Italian multicentric study. 119
Pretreatment serum hemoglobin level and a preliminary investigation of intratumoral microvessel density in advanced ovarian cancer 115
TOP2A as marker of response to pegylated lyposomal doxorubicin (PLD) in epithelial ovarian cancers 115
Pretreatment serum hemoglobin level as a predictive factor of response to neoadjuvant chemotherapy in patients with locally advanced squamous cervical carcinoma: a preliminary report 101
Hypersensitivity to platinum salts according to BRCA status in ovarian cancer: A retrospective analysis of clinical outcomes and systematic review of literature 96
Intratumoral microvessel density in advanced epithelial ovarian cancer and its use as a prognostic variable 92
Angiogenesis and molecular markers in advanced epithelial ovarian cancer: A retrospective study 89
Diagnostic Accuracy And Cost-Effectiveness Of Different Strategies To Triage Adnexal Masses: A Prospective Study 86
The cellular apoptosis susceptibility CAS/CSE1L gene protects ovarian cancer cells from death by suppressing RASSF1C 85
Characteristics and patterns of care of endometrial cancer before and during COVID-19 pandemic 74
Phase II trial with 5-fluorouracil and high-dose folinic acid, using new sequential dosing schedule, in pretreated advanced breast cancer patients. 72
TOP2A gene copy gain predicts response of epithelial ovarian cancers to pegylated liposomal doxorubicin. TOP2A as marker of response to PLD in ovarian cancer 72
Daily administration of low molecular weight heparin increases Hepatocyte Growth Factor serum levels in gynaecological patients: pharmacokinetic parameters and clinical implications. 68
Attitudes of Italian gynaecologists towards prophylactic oophorectomy at hysterectomy for non-malignant conditions 66
Behaviour of ovarian tumors of low malignant potential treated with conservative surgery 64
Medical treatment of early stage and rare histological variants of epithelial ovarian cancer 64
[The use of aminoglutethimide in the treatment of metastatic breast cancer] 62
Prognostic value of lymph node status and number of removed nodes in patients with squamous cell carcinoma of the vulva treated with modified radical vulvectomy and inguinal-femoral lymphadenectomy. 62
Can Vulnerable Elders Survey-13 predict the impact of frailty on chemotherapy in elderly patients with gynaecological malignancies? 62
Monitoring chemotherapy cardiotoxicity: how evaluate it? 58
Different types of hysterectomy in the radio-surgical treatment of early cervical cancer (FIGO Ib-IIa). 57
Complications after the treatment of endometrial cancer: a prospective study using the French-italian glossary. 56
Pre-chemotherapy hemoglobin levels and survival in patients with advanced epithelial ovarian cancer who received a first-line taxane/platinum-based regimen: results of a multicenter retrospective Italian study 55
Analysis of failures after negative second-look in patients with advanced ovarian cancer: an Italian multicenter study. 54
Analysis of the evolution in the management of endometrial cancer in Italy: a CTF study. 51
Clinical significance of microinvasion in borderline ovarian tumor and its impact on surgical management. 49
Epidermal Growth Factor Receptor (EGFR) Pathway Biomarkers in the Randomized Phase III Trial of Erlotinib Versus Observation in Ovarian Cancer Patients with No Evidence of Disease Progression after First-Line Platinum-Based Chemotherapy 45
Clinical and pharmacokinetic phase II study of pegylated liposomal doxorubicin and vinorelbine in heavily pretreated recurrent ovarian carcinoma 43
Laparoscopic treatment of endometrial cancer: feasibility and results 42
Development of a preoperative computed tomography score for the management of advanced epithelial ovarian cancer 42
Patterns of recurrence in patients with squamous cell carcinoma of the vulva. A multicenter CTF Study. 40
The clinical outcome of patients with stage Ia1 and Ia2 squamous cell carcinoma of the uterine cervix: a Cooperation Task Force (CTF) study. 40
The prognostic relevance of histological type in uterine sarcomas: a Cooperation Task Force (CTF) multivariate analysis of 249 cases. 38
Pretreatment platelet and hemoglobin levels are neither predictive nor prognostic variables for patients with locally advanced cervical cancer treated with neoadjuvant chemotherapy and radical hysterectomy: a retrospective Italian study. 37
Is there a difference in survival and in prognostic factors in stage IIA and stage IIB endometrial cancer patients? 37
Complications of the treatment of endometrial cancer: a prospective analysis using the french - italian glossary 37
Laparoscopic identification of pelvic nerves in patients with deep infiltrating endometriosis 36
Predicting Response to Anthracyclines in Ovarian Cancer 35
Malignant struma ovarii: a case report of laparoscopic management. 34
Operable breast cancer: a review of neoadjuvant chemotherapy. 33
Metastatic bilateral strumal carcinoid: A case report and review of the literature 33
Pegylated liposomal doxorubicin and vinorelbine in recurrent ovarian carcinoma: a pharmacokinetic study on alternate administration sequences 32
Clinical significance of microinvasion in borderline ovarian tumors and its impact on surgical management. 32
Secondary cytoreductive surgery for isolated lymph node recurrence of epithelial ovarian cancer: A multicenter study. 28
Gemcitabine and vinorelbine combination in platinum-sensitive recurrent ovarian cancer. 27
The clinical outcome of epithelial ovarian cancer patients with apparently isolated lymph node recurrence: a multicenter retrospective Italian study 19
Clinical pathways of recovery after surgery for advanced ovarian/tubal/peritoneal cancer: An NSGO-MaNGO international survey in collaboration with AGO - A focus on surgical aspects 15
LYMPHOVASCULAR SPACE INVASION IN ENDOMETRIAL CARCINOMA: A RETROSPECTIVE COHORT STUDY 13
LOCALLY ADVANCED CERVIX CANCER. EORTC 55994 TRIAL CLOSE TO ENDING AND ITS SUCCESSOR 9
The "Sandwich" Schedule: A Well-Tolerated Adjuvant Treatment Both in Intermediate-High- and High-Risk Endometrial Cancer 8
Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial 8
Impact of different follow-up regimens on health-related quality of life and costs in endometrial cancer patients: Results from the TOTEM randomized trial 8
Recostruttive surgery in the management of vulvar cancer: an observational study 8
A PHASE III TRIAL OF POSTOPERATIVE CHEMOTHERAPY OR NO FURTHER TREATMENT FOR PATIENTS WITH NODE-NEGATIVE STAGE I-II INTERMEDIATE-OR HIGH-RISK ENDOMETRIAL CANCER. ENGOT-EN2-DGCG/EORTC 55102 7
Chemotherapy-Induced Cardio Toxicity in Breast Cancer Survivors 7
AVM (Adriamycin, Vinblastine, Methotrexate) neoadjuvant chemotherapy in advanced or inflammatory carcinoma of the breast 7
Could a 2D/3DUSbased model be helpful in the assessment of myometrial invasion at time of intraoperative frozen section? Apilot study 7
Magnetic Resonance Imaging in cervical cancer: assessment of response to neoadjuvant chemotherapy 6
Carboplatin and pegylated liposomal doxorubicin versus carboplatin and paclitaxel in very platinum-sensitive ovarian cancer patients: Results from a subset analysis of the CALYPSO phase III trial 6
Carboplatin and pegylated liposomal doxorubicin versus carboplatin and paclitaxel in partially platinum-sensitive ovarian cancer patients: results from a subset analysis of the CALYPSO phase III trial 6
QUALITY INDICATORS (QIs) IN ADVANCED OVARIAN CANCER (AOC) MANAGEMENT 6
Ultrasonographic diagnosis of adnexal masses: interobserver agreement in the interpretation of videos, using IOTA terminology 6
The systemic treatment of recurrent ovarian cancer revisited 6
Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): patterns of recurrence and post-hoc survival analysis of a randomised phase 3 trial 6
MALNUTRITION AMONG OVARIAN CANCER PATIENTS 5
Immunonutrition in ovarian cancer: clinical and immunological impact? 5
Clinical Outcome of Patients With Malignant Tumors Associated With Mature Cystic Teratomas of the Ovary: A Retrospective Multicenter Italian Study 5
Association between ovarian endometriosis and malignancy in the peri-menopausal period: Report of two cases and review of the literature 5
FOOD HABITS AND RISK OF ENDOMETRIAL CANCER: DEVELOPMENT OF AN ASSESSMENT QUESTIONNAIRE 5
Retrospective Analysis of the Correlation of MSI-h/dMMR Status and Response to Therapy for Endometrial Cancer: RAME Study, a Multicenter Experience 5
SUCCOR study: an international European cohort observational study comparing minimally invasive surgery versus open abdominal radical hysterectomy in patients with stage IB1 cervical cancer 5
IMMUNONUTRITION: A NEW TOOL IN THE MANAGEMENT OF OVARIAN CANCER? 5
Retrospective study of histopathological and prognostic characteristics of primary fallopian tube carcinomas: twenty-year experience (SOCRATE) 5
CA-125 can be part of the tumour evaluation criteria in ovarian cancer trials: experience of the GCIG CALYPSO trial 5
Clinical, Sonographic, and Hysteroscopic Features of Endometrial Carcinoma Diagnosed after Hysterectomy in Patients with a Preoperative Diagnosis of Atypical Hyperplasia: A Single-Center Retrospective Study 4
Suspecting malignancy in endometrial polyps: value of hysteroscopy 4
Leiomyosarcoma of the Right Iliac Vein Presenting as a Pelvic Mass: A Case Report 4
QUALITY INDICATORS (QIs) IN RARE OVARIAN CANCER MANAGEMENT SUGGEST A REGIONAL-LEVEL ORGANISATION 4
Thromboembolic events and antithrombotic prophylaxis in advanced ovarian cancer patients treated with bevacizumab: secondary analysis of the phase IV MITO-16A/MaNGO-OV2A trial 4
Bevacizumab, carboplatin, and paclitaxel in the first line treatment of advanced ovarian cancer patients: the phase IV MITO-16A/MaNGO-OV2A study 4
Immunotherapy in Gynaecological Oncology: The Italian Landscape 4
Preoperative nasopharyngeal swab testing and postoperative pulmonary complications in patients undergoing elective surgery during the SARS-CoV-2 pandemic 4
Fifth ovarian cancer consensus conference of the gynecologic cancer intergroup: Recurrent disease 4
European experts consensus: BRCA/homologous recombination deficiency testing in first-line ovarian cancer 4
Laparoscopic dissection of the ureter for radical laparoscopic hysterectomy 3
ESMO-ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease 3
Safety of cytotoxic drug handling, preparation, storage, etc.: the role of the pharmacists and nurses 3
EANM guideline on the role of 2-[18F]FDG PET/CT in diagnosis, staging, prognostic value, therapy assessment and restaging of ovarian cancer, endorsed by the American College of Nuclear Medicine (ACNM), the Society of Nuclear Medicine and Molecular Imaging (SNMMI) and the International Atomic Energy Agency (IAEA) 3
Practice patterns and 90-day treatment-related morbidity in early-stage cervical cancer 3
Factors associated with adherence to BRCA1/2 mutation testing after oncogenetic counseling in long-surviving patients with a previous diagnosis of breast or ovarian cancer 3
The retrograde and retroperitoneal totally laparoscopic hysterectomy for endometrial cancer 3
The appropriate use of G-CSF in ovarian neoplasm 3
SUCCOR cone study: conization before radical hysterectomy 3
Impact of Bevacizumab-containing Primary Treatment on Outcome of Recurrent Ovarian Cancer: An Italian Study 2
Totale 4.423
Salva come PNG Salva come JPEG
Categoria #
all - tutte 16.271
article - articoli 0
book - libri 0
conference - conferenze 546
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.817
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019190 0 0 0 0 0 0 0 0 0 45 104 41
2019/2020765 57 75 54 78 72 85 72 57 73 69 40 33
2020/2021405 33 38 51 17 27 24 26 22 45 41 19 62
2021/2022478 14 33 13 23 20 22 29 19 18 47 116 124
2022/2023858 73 43 18 38 75 197 65 75 91 16 146 21
2023/2024429 68 84 45 49 31 44 33 25 14 36 0 0
Totale 4.477